Formulation Strategies and Therapeutic Applications of Shikonin and Related Derivatives.
Shikonin
anticancer
antimicrobial
nano formulations
patents
wound healing
Journal
Recent advances in drug delivery and formulation
ISSN: 2667-3886
Titre abrégé: Recent Adv Drug Deliv Formul
Pays: Netherlands
ID NLM: 101776133
Informations de publication
Date de publication:
2022
2022
Historique:
received:
16
11
2021
revised:
11
01
2022
accepted:
11
01
2022
pubmed:
4
3
2022
medline:
26
5
2022
entrez:
3
3
2022
Statut:
ppublish
Résumé
Shikonin and its derivatives are excellent representatives of biologically active naphthoquinones. A wide range of investigations carried out in the last few decades validated their pharmacological efficacy. Besides having magnificent therapeutic potential, shikonin and its derivatives suffer from various pharmacokinetic, toxicity, and stability issues like poor bioavailability, nephrotoxicity, photodegradation, etc. Recently, various research groups have developed an extensive range of formulations to tackle these issues to ease their path to clinical practice. The latest formulation approaches have been focused on exploiting the unique features of novel functional excipients, which in turn escalate the therapeutic effect of shikonin. Moreover, the codelivery approach in various drug delivery systems has been taken into consideration in a recent while to reduce toxicity associated with shikonin and its derivatives. This review sheds light on the essential reports and patents published related to the array of formulations containing shikonin and its derivatives.
Identifiants
pubmed: 35236278
pii: RADDF-EPUB-121240
doi: 10.2174/2667387816666220302112201
doi:
Substances chimiques
Naphthoquinones
0
shikonin
3IK6592UBW
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
55-67Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.